LGES Q1 2026 — Two Second Derivatives Moving in Opposite Directions

LGES's ex-incentive operating loss narrowed to approximately KRW -398B in Q1 2026 from KRW -455B in Q4 2025. The North American production incentive that covers that loss fell faster, from KRW 332.8B to KRW 189.8B, driven by declining EV pouch volume. Reported operating loss therefore widened QoQ to KRW -208B. The company is marginally healthier underneath and visibly worse on the surface. The subsidy bridge is shortening from both ends. LGES remains the most actionable Korean supplier file precisely because its disclosure transparency makes these dynamics legible in a way that Samsung SDI's and SK On's undisclosed incentive exposure does not permit.

Trailing Four-Quarter Decomposition

All figures from LGES Q1 2026 English IR materials, using restated 2025 quarterly figures under FY2026 presentation basis (which consolidates North American production incentives into revenue). USD equivalents use Q1 2026 average KRW 1,465.57/USD per FRED DEXKOUS. Analysis relies on English-language IR summaries, not Korean-language earnings call transcripts.

^1^ No quarterly utilization disclosed. Full-year 2025: 47.6%, down from 57.8% in 2024 (Seoul Economic Daily, Mar. 16, 2026). No Q1 2026 estimate from TrendForce was identified in reviewed sources. ^2^ LGES does not disclose EV/ESS revenue or shipment split at the quarterly level. ^3^ Q1 2026 English IR materials contain no ASP disclosure or directional guidance.

45X Isolation

Read the incentive column left to right. KRW 491B, 365B, 332.8B, 189.8B. Four consecutive quarterly declines, with the Q1 2026 drop the steepest at KRW 143B, or 43% QoQ. LGES attributed the decline to "inventory adjustment by a major North American customer," which reduced EV pouch shipments from US plants. The 45X credit is a function of eligible US production volume. When EV output falls, the credit contracts mechanically.

Now read the ex-incentive row. KRW 1B, 236B, -455B, -398B. Q3 2025 was the high-water mark for underlying economics in this trailing window. Q4 collapsed by KRW 691B in a single quarter. The English IR materials do not decompose what drove that deterioration. Whether it included one-time charges, write-downs, or Stellantis JV-related impairments is not discernible from the reviewed Q4 2025 deck or LG Corp's FY2025 release. This matters because Q1's KRW 57B improvement reads as a genuine inflection if Q4 was a structural step-down, and as a partial bounce from an anomalous trough if Q4 contained non-recurring items. The baseline is unclean, and the English-language disclosures do not resolve it.

Taking the improvement at face value: KRW 57B against a KRW 398B loss is a 14% reduction. Revenue grew KRW 81B sequentially while the ex-incentive loss narrowed KRW 57B. Whether that improvement came from the top line (ESS volume gains, better mix) or the cost line (fixed-cost absorption, lower input costs) cannot be determined from the Q1 deck, which cites both ESS volume increases and "initial ramp-up cost from ESS production-site expansion" as offsetting forces. The durability of the improvement depends on which force dominated, and the disclosure doesn't say.

LGES remains the only Korean cell maker that discloses this bridge at the quarterly level. Samsung SDI and SK On do not provide comparable 45X breakouts. Their reported figures may contain similar or larger subsidy contributions that remain invisible.

Utilization Trend

No Q1 2026 quarterly utilization was disclosed. No Q1 2026 estimate from TrendForce was identified in reviewed sources. The trailing annual series from SMM and Seoul Economic Daily:

The rate of decline was still severe in 2025 but decelerated slightly from 2024's pace. Whether that deceleration continued into Q1 2026 cannot be confirmed.

Qualitative signals from the Q1 deck are mixed. EV cylindrical shipments were "stable." EV pouch shipments declined. ESS volume increased. LGES is expanding ESS capacity at Holland and Lansing, Michigan, and temporarily converting some Stellantis JV and Honda JV lines for ESS output. Whether the ESS volume gain offset the EV pouch decline in aggregate utilization terms is not discernible from the English IR materials.

The denominator question compounds this. LGES guided for global ESS capacity above 60 GWh in 2026. If new capacity comes online while total shipments grow only modestly, utilization falls further even as absolute volumes rise. Without quarterly disclosure, the next clean read arrives with FY2026 annual figures in early 2027. That is too late for a procurement team making qualification decisions in H2 2026.

Guidance vs. Actuals

LGES guided during Q4 2025 earnings for mid-teen to 20% YoY revenue growth in FY2026 and a mid-single-digit operating profit margin including NA production incentives.

Q1 delivered KRW 6.555T revenue and KRW -208B operating loss. The full-year guidance implies significant back-half loading. Approximate arithmetic: if FY2026 revenue tracks to roughly KRW 27-28T (consistent with the guided growth range applied to a ~KRW 24-25T FY2025 base), a mid-single-digit margin implies KRW 1.35-1.4T in full-year operating profit. After Q1's KRW -208B, the remaining three quarters need to generate approximately KRW 520-550B per quarter on average. For context, the best reported quarter in the trailing window was Q3 2025 at KRW 601B, which included KRW 365B in production incentives. Hitting guidance requires either a sharp ESS revenue ramp, a recovery in EV pouch volumes, or both.

Capex is tracking. Q1 capex of KRW 1.6T was down 47% YoY against guidance of >40% YoY reduction. This is the one metric where execution matches stated intent cleanly.

On ESS orders, LGES targeted >90 GWh of new ESS orders in 2026, primarily from North American utility-scale buyers. Post-Q1 signals suggest real progress: the DTE Energy 6 GWh agreement sources cells from Michigan and other US and Canadian facilities; NextStar's Windsor pack line began production in June 2026; the Tesla/Lansing $4.3B LFP prismatic supply deal targets 2027 SOP for Megapack 3. Substantive proof points, all of them — named customers, named facilities, disclosed commercial terms — and all of them forward commitments with no Q1 operating-line contribution.

The ESS order pipeline and the income statement are separated by time. The orders exist, the capacity is being built, and the ramp-up costs are hitting now while the margin contribution arrives later. The next two quarters should begin to close that distance, or at least make visible whether it is closing.

On LFP conversion, LGES guided for mass production of LFP and high-voltage mid-nickel batteries beginning Q1 2026. The Q1 deck does not quantify LFP output or yields. The Tesla/Lansing deal, specifying LFP prismatic cells with 2027 SOP, confirms commitment to the chemistry transition. But 2027 SOP means qualification and yield optimization are still ahead. Korean LFP learning curves typically run 3-5 years from pilot to stable yields (editorial assessment based on historical NMC-to-LFP conversion timelines; no single published source). LGES is attempting to compress that to 2-3 years. Whether it succeeds is not yet visible in any disclosed figure.

Sourcing Decision Frame

For a team evaluating LGES as a cell supplier, Q1 2026 shifts the risk profile in a specific direction. The underlying economics improved marginally. The ESS proof file is denser than any other Korean maker's: real contracts with DTE, Tesla, and NextStar; real capacity under construction in Michigan; real LFP prismatic development for a named customer. That file is the strongest forward-looking case for any FEOC-compliant cell supplier in the US market.

It sits beside a present-state operating loss that widened on a reported basis because the subsidy bridge is eroding. LGES gives you more data to price the risk than Samsung SDI or SK On, whose 45X exposure remains undisclosed. That disclosure transparency is a genuine procurement advantage. The underlying risk reads differently depending on your delivery horizon. A team sourcing for H2 2026 is qualifying a subsidized-loss supplier with a credible but unproven path to organic margin. A team qualifying for 2027-2028 delivery weighs the ESS pipeline and LFP conversion trajectory more heavily, and both are tracking against guidance without yet producing financial proof.